MedKoo Cat#: 461278 | Name: Gyki 32887

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Gyki 32887 is a compound that acts as a dopamine agonist.

Chemical Structure

Gyki 32887
Gyki 32887
CAS#78463-86-2

Theoretical Analysis

MedKoo Cat#: 461278

Name: Gyki 32887

CAS#: 78463-86-2

Chemical Formula: C23H28N6O6S

Exact Mass:

Molecular Weight: 516.57

Elemental Analysis: C, 53.48; H, 5.46; N, 16.27; O, 18.58; S, 6.21

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Gyki 32887; Gyki-32887; Gyki32887; RGH-7825; RGH 7825; RGH7825;
IUPAC/Chemical Name
N-(2-azidoethyl)-N-(((6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl)methyl)methanesulfonamide maleate
InChi Key
BOHDKBGWKRCEIT-VQAQLOKVSA-N
InChi Code
InChI=1S/C19H24N6O2S.C4H4O4/c1-24-11-13(12-25(28(2,26)27)7-6-22-23-20)8-16-15-4-3-5-17-19(15)14(10-21-17)9-18(16)24;5-3(6)1-2-4(7)8/h3-5,8,10,16,18,21H,6-7,9,11-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-,18-;/m1./s1
SMILES Code
CS(=O)(N(CCN=[N+]=[N-])CC1=C[C@]2([C@]([H])(N(C)C1)CC3=CNC4=C3C2=CC=C4)[H])=O.O=C(O)/C=C\C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 516.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Király I, Van Ree JM. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats. Neuropharmacology. 1984 May;23(5):511-6. PubMed PMID: 6204246. 2: Berzétei IP, Bagdy E, Hardy M, Borsy J. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors. Pol J Pharmacol Pharm. 1985 May-Jun;37(3):237-42. PubMed PMID: 4070077. 3: Borsy J. New central dopamine agonists. Pol J Pharmacol Pharm. 1985 May-Jun;37(3):227-36. Review. PubMed PMID: 2999737. 4: Jaszlits L, Tardos L, Borsy J. The role of central dopamine (DA) receptors in the regulation of blood pressure. Pol J Pharmacol Pharm. 1985 May-Jun;37(3):405-10. PubMed PMID: 4070082.